FLGT · NASDAQ · Medical - Diagnostics & Research

Fulgent Genetics (FLGT)

Combines hereditary-cancer and pathology testing with a nanoencapsulated cancer-drug pipeline in clinical trials.

$21.80
vs last close+0.26 (+1.22%)